Central IRB Services for NIAID Coronavirus COVID-19 OWS ACTIV-3 Clinical Trial
$718,961N02FY2020AINIH
Medical Science & Computing, Llc, Rockville MD
Investigators
Abstract
The purpose of this funding is to provide the Central Institutional Review Board (IRB) services for the Coronavirus COVID-19 ACTIV-3 trial.
View original record on NIH RePORTER →